HCW Biologics Inc.
HCWB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828673
In the last 90 days, HCW Biologics Inc. insiders filed 3 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $515.7K in total; no superinvestor holds it.
Holders of 5% or more of HCWB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of HCW Biologics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Wong Hing C | 13D/A | 23.38%501.9K shares | – | Jun 13, 20251 filing | Jun 13, 2025 | SEC |
| Armistice Capital, LLC | 13G | 9.99%401.0K shares | New | Feb 17, 20261 filing | Feb 17, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on HCW Biologics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 20269:50 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%401.0K shares | New | Dec 31, 2025 | SEC |
| Jun 13, 20254:30 PM ET | Wong Hing C | 13D/A | 23.38%501.9K shares | – | May 15, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell HCW Biologics Inc. shares.
No Form 144 notices for HCW Biologics Inc. are on file.